Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure

Vascular Pharmacology(2025)10.1016/j.vph.2025.107530Source: DataRank Database

Sodium-glucose cotransporter 2 inhibition restores testicular microvascular perfusion via endothelial signaling in a large animal model of metabolic syndrome and heart failure is a research paper published in Vascular Pharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.07)OA: hybridTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Christopher Stone ORCID,Dwight D. Harris ORCID,Kelsey Muir ORCID,Keertana Yalamanchili,Nicholas Sellke ORCID

Live enrichment

PubMed:40848868 OpenAlex:https://openalex.org/W4413386305

National Institutes of Health

Grant: R01HL128831

National Institutes of Health

Grant: T32HL160517

Foundation for the National Institutes of Health

FWCI

1.07

Citation Percentile

0.8%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.vph.2025.107530

HYBRIDhttps://doi.org/10.1016/j.vph.2025.107530

publisherhttps://doi.org/10.1016/j.vph.2025.107530

publisherhttps://api.elsevier.com/content/article/PII:S1537189125000692?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1537189125000692?httpAccept=text/plain

Fields of Study

Testicular diseases and treatmentsDiabetes Treatment and ManagementUrinary Bladder and Prostate ResearchMedicineEnvironmental Science

MeSH Terms

CanagliflozinSodium-Glucose Transporter 2 InhibitorsAnimalsDisease Models, AnimalEndothelium, VascularHeart FailureMaleMicrocirculationTestisSignal TransductionApoptosisMetabolic SyndromeSus scrofaAMP-Activated Protein KinasesMicrovessels

Keywords

PerfusionInternal medicineEndocrinologyHeart failureCotransporterCardiologyMedicineChemistrySodiumCardiometabolic DiseaseEndothelial SignalingTesticular PerfusionSglt2 Inhibitors (Canagliflozin)Peripheral Microvascular Dysfunction

Sustainable Development Goals

SDG 0: Good health and well-being